Proactive Investors - Run By Investors For Investors

Vector Therapeutics using technology to try and prevent acute Leukemia relapse

Vector Therapeutics Corp CEO Daniel Teper  updates Proactive Investor's Christine Corrado at the 11th Annual Biotech Showcase in San Francisco. The New York based pharma company is focused on providing life-changing, precision-immunotherapy treatments for a variety of cancers, mainly leukemia.

View full VECTO profile View Profile

Vector Therapeutics Timeline

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use